Mirum Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) on April 6, 2023, covering events that occurred on April 5, 2023. The filing addresses changes to the Company's Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Appointment of Director: The Board appointed Timothy Walbert as a Class I director, effective immediately. His initial term expires at the 2023 Annual Meeting of Stockholders.
- Resignation of Director: Niall O'Donnell, Ph.D., resigned as a director and member of the Nominating and Corporate Governance Committee, effective as of the 2023 Annual Meeting of Stockholders. The resignation was not due to any dispute with the Company.
Compensatory Arrangements and Outlook
Mr. Walbert's appointment includes the following compensatory arrangements under the Company's Non-Employee Director Compensation Policy:
- Stock Option Grant: An option to purchase 34,000 shares of common stock, vesting in three equal annual installments subject to continuous service.
- Cash Retainer: An annual cash retainer of $45,000, pro-rated for 2023.
- Future Grants: Eligibility for an annual option grant of 17,000 shares commencing with the 2023 Annual Meeting, pro-rated based on months served.
The filing states there are no related person transactions or undisclosed arrangements regarding Mr. Walbert's selection.
Investor Verification Checklist
- Verify the exact vesting schedule and exercise price of the 34,000 shares granted to Timothy Walbert in subsequent filings (e.g., Form 4).
- Confirm the date of the 2023 Annual Meeting of Stockholders to determine the effective date of Dr. O'Donnell's resignation.
- Review the Company's latest 10-K or 10-Q for current financial liquidity and cash runway, as this 8-K does not contain financial data.